Cargando…

Increased oxidative stress and severe arterial remodeling induced by permanent high-flow challenge in experimental pulmonary hypertension

BACKGROUND: Involvement of inflammation in pulmonary hypertension (PH) has previously been demonstrated and recently, immune-modulating dendritic cells (DCs) infiltrating arterial lesions in patients suffering from idiopathic pulmonary arterial hypertension (IPAH) and in experimental monocrotaline-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dorfmüller, Peter, Chaumais, Marie-Camille, Giannakouli, Maria, Durand-Gasselin, Ingrid, Raymond, Nicolas, Fadel, Elie, Mercier, Olaf, Charlotte, Frédéric, Montani, David, Simonneau, Gérald, Humbert, Marc, Perros, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189121/ https://www.ncbi.nlm.nih.gov/pubmed/21906276 http://dx.doi.org/10.1186/1465-9921-12-119

Ejemplares similares

N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats
por: Chaumais, Marie-Camille, et al.
Publicado: (2014)

The Beneficial Effect of Suramin on Monocrotaline-Induced Pulmonary Hypertension in Rats
por: Izikki, Mohamed, et al.
Publicado: (2013)

Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension
por: Perros, Frédéric, et al.
Publicado: (2021)

Description, Staging and Quantification of Pulmonary Artery Angiophagy in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
por: Perros, Frédéric, et al.
Publicado: (2020)

Pulmonary capillary haemangiomatosis: a distinct entity?
por: Weatherald, Jason, et al.
Publicado: (2020)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Chronic thromboembolic pulmonary hypertension complicating long-term cyproterone acetate therapy
por: Montani, David, et al.
Publicado: (2014)

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension
por: Hautefort, Aurélie, et al.
Publicado: (2017)

Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous
por: Perros, Frédéric, et al.
Publicado: (2019)

Key Role of the Endothelial TGF-β/ALK1/Endoglin Signaling Pathway in Humans and Rodents Pulmonary Hypertension
por: Gore, Benoît, et al.
Publicado: (2014)

Factors predicting outcome after pulmonary endarterectomy
por: Tromeur, Cécile, et al.
Publicado: (2018)

Pulsatile pulmonary artery pressure in a large animal model of chronic thromboembolic pulmonary hypertension: Similarities and differences with human data
por: Boulate, David, et al.
Publicado: (2022)

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Brenot, Philippe, et al.
Publicado: (2019)

Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells
por: Price, Laura C., et al.
Publicado: (2015)

Pulmonary Hypertension Complicating Fibrosing Mediastinitis
por: Seferian, Andrei, et al.
Publicado: (2015)

Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis
por: Hlavaty, Alex, et al.
Publicado: (2022)

The pathophysiology of chronic thromboembolic pulmonary hypertension
por: Simonneau, Gérald, et al.
Publicado: (2017)

Pulmonary hypertension associated with diazoxide: the SUR1 paradox
por: Montani, David, et al.
Publicado: (2023)

Pulmonary hypertension associated with busulfan
por: Hagenburg, Jean, et al.
Publicado: (2021)

Trichloroethylene increases pulmonary endothelial permeability: implication for pulmonary veno-occlusive disease
por: Caliez, Julien, et al.
Publicado: (2020)

Iron deficiency in pulmonary arterial hypertension: perspectives
por: Quatredeniers, Marceau, et al.
Publicado: (2021)

Pulmonary hypertension associated with neurofibromatosis type 1
por: Jutant, Etienne-Marie, et al.
Publicado: (2018)

Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure
por: Hautbergue, Thaïs, et al.
Publicado: (2021)

Lipidomic Profile Analysis of Lung Tissues Revealed Lipointoxication in Pulmonary Veno-Occlusive Disease
por: Khoury, Spiro, et al.
Publicado: (2022)

Nuclear Factor κ-B Is Activated in the Pulmonary Vessels of Patients with End-Stage Idiopathic Pulmonary Arterial Hypertension
por: Price, Laura C., et al.
Publicado: (2013)

In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression
por: Le Ribeuz, Hélène, et al.
Publicado: (2020)

Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension
por: Girerd, Barbara, et al.
Publicado: (2010)

Sex and gender in pulmonary arterial hypertension
por: Cheron, Céline, et al.
Publicado: (2021)

A rare case of sarcoidosis-associated pulmonary hypertension in a patient exposed to silica
por: Bourlier, Delphine, et al.
Publicado: (2016)

Role of Store-Operated Ca(2+) Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension
por: Masson, Bastien, et al.
Publicado: (2021)

An emerging phenotype of pulmonary arterial hypertension patients carrying SOX17 variants
por: Montani, David, et al.
Publicado: (2022)

Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension
por: Guimaron, Samantha, et al.
Publicado: (2018)

Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery
por: Sage, Edouard, et al.
Publicado: (2008)

Bromodomain and extra‐terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: Implications for pulmonary arterial hypertension
por: Mumby, Sharon, et al.
Publicado: (2016)

Role of adjuvant radiotherapy in completely resected non-small-cell lung cancer
por: Péchoux, Cecile Le, et al.
Publicado: (2013)

BET Bromodomain Inhibitors and Pulmonary Arterial Hypertension: Take Care of the Heart
por: Piquereau, Jérôme, et al.
Publicado: (2019)

Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension
por: Grynblat, Julien, et al.
Publicado: (2023)

Echocardiographic evaluations of right ventriculo–arterial coupling in experimental and clinical pulmonary hypertension
por: Boulate, David, et al.
Publicado: (2019)

The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats
por: Piquereau, Jérôme, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jfh5802i21h1nmsi2mguv4l725